Biotechs Get Turbo A Boost From Biogen

Risk is on for biotech. Biotech stocks should be higher by year-end. Earnings on major large caps need to support rally.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.